Tag Archives: SignPath Pharma Inc.

FINRA Fines Meyers Associates For Misleading Content

January 26, 2018  |   Posted by :   |   Investment and Regulatory News   |   0 Comments

Meyers Associates, L.P. (now known as Windsor Street Capital, L.P.) has been censured and fined $700,000.00 and its president, Bruce Meyers, fined $100,000.00 and barred in a supervisory capacity by Financial Industry Regulatory Authority (FINRA) according to a National Adjudicatory Council Decision confirming that Meyers, inter alia, had disseminated misleading and unbalanced investment related communications […]

Read More »